Peak Pharma Reports Initial Canna-Pet Revenue with 72.7% Gross Margin

Management's long-term focus on profitability is highlighted by its hemp ... Peak Pharmaceuticals' hemp-based CBD-infused Canna-Pet™ products.



from Google Alert - cbd hemp http://ift.tt/1D3O14R

via IFTTT ** Interested in building your own business with hemp? Go now! http://ift.tt/SbMGZP **